Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
4.920
+0.030 (0.61%)
At close: Aug 26, 2026, 4:00 PM EDT
5.01
+0.09 (1.83%)
After-hours: Aug 26, 2026, 6:04 PM EDT
Evolent Health Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 115.7 | 151.86 | 104.2 | 192.83 | 188.2 | 266.28 |
Cash & Short-Term Investments | 115.7 | 151.86 | 104.2 | 192.83 | 188.2 | 266.28 |
Cash Growth | -23.37% | 45.73% | -45.96% | 2.46% | -29.32% | -16.53% |
Accounts Receivable | 449.12 | 309.86 | 414.68 | 446.75 | 254.68 | 130.6 |
Receivables | 449.12 | 309.86 | 414.68 | 446.75 | 254.68 | 130.6 |
Prepaid Expenses | 22.7 | 18.52 | 28.94 | 30.33 | 20.68 | 51.39 |
Restricted Cash | 22.99 | 26.13 | 59.3 | 13.77 | 14.49 | 75.69 |
Total Current Assets | 610.51 | 506.37 | 607.12 | 683.67 | 478.05 | 523.96 |
Property, Plant & Equipment | 4.93 | 7.36 | 10.59 | 19.28 | 63.2 | 60.37 |
Long-Term Investments | 8.76 | 8.97 | 8.59 | 4.9 | 4.48 | 5.46 |
Goodwill | 694.43 | 694.48 | 1,137 | 1,117 | 722.77 | 426.3 |
Other Intangible Assets | 634.13 | 662.74 | 748.86 | 822.91 | 516.48 | 350.98 |
Long-Term Accounts Receivable | - | - | - | - | - | 4.88 |
Long-Term Deferred Tax Assets | - | 2 | 1.5 | 1 | - | - |
Long-Term Deferred Charges | 14.05 | 13.54 | 13.38 | 12.12 | 17.46 | 32.62 |
Other Long-Term Assets | 5.08 | 3.78 | 17.07 | 19.89 | 14.84 | 14.89 |
Total Assets | 1,972 | 1,899 | 2,544 | 2,680 | 1,817 | 1,419 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 38.82 | 59.78 | 96.03 | 48.25 | 57.17 | 96.08 |
Accrued Expenses | 72.86 | 116.74 | 100.08 | 206.23 | 163.66 | 159.1 |
Current Portion of Long-Term Debt | - | - | 171.47 | - | - | - |
Current Portion of Leases | 1.54 | 15.34 | 26.72 | 9.74 | 7.12 | 7.07 |
Current Unearned Revenue | 1.21 | 1.2 | 2.51 | 5.98 | 5.76 | 11.94 |
Other Current Liabilities | 378.4 | 192.2 | 318.71 | 404.05 | 199.73 | 171.29 |
Total Current Liabilities | 492.83 | 385.26 | 715.5 | 674.24 | 433.44 | 445.49 |
Long-Term Debt | 966.47 | 970.54 | 490.52 | 597.05 | 412.99 | 215.68 |
Long-Term Leases | 2.43 | 3.82 | 24.97 | 38.01 | 56.01 | 57.72 |
Long-Term Unearned Revenue | - | 0.11 | - | 1.17 | 2.53 | 4.44 |
Long-Term Deferred Tax Liabilities | 9.94 | 7.51 | 10.9 | 13.31 | 4.74 | 1.4 |
Other Long-Term Liabilities | 117 | 116.81 | 111.09 | 110.4 | 48.16 | 1.09 |
Total Liabilities | 1,589 | 1,484 | 1,353 | 1,434 | 957.88 | 725.83 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.19 | 1.18 | 1.17 | 1.15 | 1.02 | 0.91 |
Additional Paid-In Capital | 1,817 | 1,793 | 1,804 | 1,808 | 1,487 | 1,341 |
Retained Earnings | -1,370 | -1,315 | -780.82 | -719.19 | -606.15 | -626.78 |
Treasury Stock | -61.43 | -61.43 | -21.12 | -21.12 | -21.12 | -21.12 |
Comprehensive Income & Other | -3.63 | -2.62 | -1.75 | -1.26 | -1.18 | -0.36 |
Total Common Equity | 383.22 | 415.19 | 1,001 | 1,068 | 859.42 | 693.63 |
Shareholders' Equity | 383.22 | 415.19 | 1,191 | 1,246 | 859.42 | 693.63 |
Total Liabilities & Equity | 1,972 | 1,899 | 2,544 | 2,680 | 1,817 | 1,419 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 970.43 | 989.7 | 713.67 | 644.8 | 476.12 | 280.47 |
Net Cash (Debt) | -854.73 | -837.84 | -609.47 | -451.97 | -287.92 | -14.19 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -7.60 | -7.34 | -5.31 | -4.06 | -3.07 | -0.16 |
Filing Date Shares Outstanding | 113.06 | 111.64 | 115.05 | 113.89 | 109.51 | 89.29 |
Total Common Shares Outstanding | 112.68 | 111.63 | 115.04 | 113.89 | 99.96 | 89.22 |
Working Capital | 117.68 | 121.11 | -108.38 | 9.43 | 44.61 | 78.47 |
Book Value Per Share | 3.40 | 3.72 | 8.70 | 9.38 | 8.60 | 7.77 |
Tangible Book Value | -945.34 | -942.03 | -884.92 | -871.75 | -379.84 | -83.65 |
Tangible Book Value Per Share | -8.39 | -8.44 | -7.69 | -7.65 | -3.80 | -0.94 |
Machinery | 15.87 | 16.99 | 15.72 | 22.8 | 34.31 | 25.55 |
Leasehold Improvements | 0.79 | 1.44 | 1.48 | 1.05 | 14.93 | 15.33 |